New amidino derivatives and their use as thrombin inhibitors
申请人:AstraZeneca AB
公开号:US20020022612A1
公开(公告)日:2002-02-21
There is provided compounds of formula I,
1
wherein R
1
, R
x
, Y, R
y
, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS
申请人:AstraZeneca AB
公开号:EP1012140A1
公开(公告)日:2000-06-28
US6265397B1
申请人:——
公开号:US6265397B1
公开(公告)日:2001-07-24
US6576657B2
申请人:——
公开号:US6576657B2
公开(公告)日:2003-06-10
[EN] NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS<br/>[FR] NOUVEAUX DERIVES D'AMIDINO ET LEUR UTILISATION COMME INHIBITEURS DE LA THROMBINE
申请人:ASTRA AKTIEBOLAG
公开号:WO1998057932A1
公开(公告)日:1998-12-23
(EN) There is provided compounds of formula (I), wherein R1, Rx, Y, Ry, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.(FR) L'invention concerne des composés de la formule (I) où R1, Rx, Y, Ry, n et B ont la signification donnée dans la description. Ces composés sont utiles comme inhibiteurs compétitifs de protéases de type trypsine, tels que la thrombine, et plus particulièrement dans le traitement d'états nécessitant l'inhibition de la thrombine (p.ex. thrombose) ou comme anticoagulants.